NCT07198971 (TEMPOS) is a NA clinical trial of Music therapy in Cancer (With or Without Metastasis), sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

Who is sponsoring NCT07198971?

NCT07198971 is sponsored by Institut du Cancer de Montpellier - Val d'Aurelle.

What drugs are being tested in NCT07198971?

Interventions in NCT07198971: Music therapy.

What condition does NCT07198971 study?

NCT07198971 studies Cancer (With or Without Metastasis).

Is NCT07198971 still recruiting?

NCT07198971 is currently recruiting now. Last updated 9 April 2026.

Last reviewed 2026-04-09 · How we verify

NCT07198971: TEMPOS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility Study Incorporating Music Therapy to Optimise the Smoking Cessation Process Coordinated by a Tobacco Addiction Nurse in Smoking Patients Being Treated for Cancer

Recruiting now NA Last updated 9 April 2026

What this trial tests

NA trial testing Music therapy in Cancer (With or Without Metastasis) in 26 participants. Currently enrolling.

Timeline

18 February 2026

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	Institut du Cancer de Montpellier - Val d'Aurelle
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	26
Start date	18 February 2026
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across France

Drugs / interventions tested

Music therapy

Conditions studied

Cancer (With or Without Metastasis) — all drugs for Cancer (With or Without Metastasis) →

Sponsor

Institut du Cancer de Montpellier - Val d'Aurelle — full company profile →

Who can join

18 and older, any sex, with Cancer (With or Without Metastasis). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The innovative nature of this project lies in the combination of three types of intervention: tobacco addiction treatment, music therapy and therapeutic education. Three disciplines that work together. 1. Tobacco addiction treatment: reducing consumption, quitting, 2. Music therapy: acting on emotions and reward circuits, 3. Therapeutic education: promoting independent healthy practices. Patients learn to use the soundtrack independently to help them manage withdrawal symptoms caused by reducing or stopping tobacco consumption. In this programme, patients play an active role on several levels: * working with the music therapist to create a personalised 'soundtrack'; * identifying situations in which music can help them manage withdrawal symptoms; * using music independently in their everyday lives. The music therapy protocol will be proposed in this study, the soundtrack is co-created by the music therapist and the patient based on the patient's musical tastes and needs. The fact that the patient can use the musical tool independently also gives them significant leverage in their withdrawal process, allowing them to act on withdrawal symptoms and the main factors contributing to relapse.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Music therapy

Trials testing the same drug.

NCT04155528 — Effect of Music Therapy on Postoperative Health Outcomes · NA · not yet recruiting
NCT07218055 — Assessment of Music Experiences in Navigating Depression Part 2 · NA · recruiting
NCT06995092 — Rhythmic Auditory Stimulation as Pre-Gait Training for Improving Balance and Weight Shifting in Rehabilitation Patients · NA · completed
NCT06853158 — MULTIsite Feasibility of MUSIc Therapy to Address Quality Of Life in Sickle Cell Disease · NA · recruiting
NCT07425847 — The Effect of Music Therapy and the 4-7-8 Breathing Exercise · NA · completed

Other recruiting trials for Cancer (With or Without Metastasis)

Currently open trials in the same condition.

NCT07290309 — Survivors Uniting for Remote Guided Exercise · NA · recruiting

Other Institut du Cancer de Montpellier - Val d'Aurelle trials

Trials by the same sponsor.

NCT07523152 — Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With H · NA · not yet recruiting
NCT07043543 — Evaluation of the Clinical Utility of Online Adaptive Radiotherapy in Bladder Cancer (BLADAPT-GETUG V11) · NA · not yet recruiting
NCT07441941 — Single-Fraction Pulmonary Ablative Radiotherapy Outcomes and Quality-of-life Workup · recruiting
NCT06382818 — Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability · NA · recruiting
NCT06053086 — SAHARA-04 : Adaptive Radiotherapy in Hypersensitive Patients and High Locoregional Risk Breast Cancer With ETHOS Technol · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07198971 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Institut du Cancer de Montpellier - Val d'Aurelle
Last refreshed: 9 April 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07198971.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing